Rakovina Therapeutics Inc. RKVTF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 40.42% | 19.59% | -27.75% | -67.36% | -249.17% |
| Total Depreciation and Amortization | 3.83% | 6.41% | 1.55% | -1.01% | -1.13% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 567.26% | 42.63% | 54.61% | 1,161.42% | -33.88% |
| Change in Net Operating Assets | 178.90% | -8.20% | 326.12% | 113.30% | -257.76% |
| Cash from Operations | 64.00% | 39.70% | 70.13% | 26.59% | -581.05% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -97.89% | -- | -- | -- | 193.97% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 156.69% | 75.00% | -220.22% |
| Cash from Financing | -85.43% | -- | -100.00% | -109.47% | 190.01% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -121.34% | 124.28% | -149.70% | 7.17% | 47.80% |